» Articles » PMID: 31742995

Identification of Quinolinols As Activators of TEAD-Dependent Transcription

Abstract

The transcriptional co-regulators YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif) are the vertebrate downstream effectors of the Hippo signaling pathway that controls various physiological and pathological processes. YAP and TAZ pair with the TEAD (TEA domain) family of transcription factors to initiate transcription. We previously identified a tractable pocket in TEADs, which has been physiologically shown to bind palmitate. Herein, a TEAD-palmitate interaction screen was developed to select small molecules occupying the palmitate-binding pocket (PBP) of TEADs. We show that quinolinols were TEAD-binding compounds that augment YAP/TAZ-TEAD activity, which was verified using TEAD reporter assay, RT-qPCR, and RNA-Seq analyses. Structure-activity relationship investigations uncovered the quinolinol substituents that are necessary for TEAD activation. We reveal a novel mechanism where quinolinols stabilize YAP/TAZ protein levels by occupying the PBP. The enhancement of YAP activity by quinolinols accelerates the wound closure in a mouse wound-healing model. Although small molecules that occupy the PBP have been shown to inhibit YAP/TAZ-TEAD activity, leveraging PBP to activate TEADs is a novel approach.

Citing Articles

Exploring structural and biological insights of TEAD through rational design and synthesis of niflumic acid derivatives.

Choi Y, Kim Y, Jeon Y, Kang J, Lee J, Hong E J Enzyme Inhib Med Chem. 2024; 39(1):2419925.

PMID: 39494490 PMC: 11536644. DOI: 10.1080/14756366.2024.2419925.


Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.

Haripriya E, Hemalatha K, Matada G, Pal R, Das P, Ashadul Sk M Mol Divers. 2024; .

PMID: 39436581 DOI: 10.1007/s11030-024-11009-1.


Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket.

Kim J, Jin H, Kim J, Cho S, Moon S, Wang J Int J Mol Sci. 2024; 25(10).

PMID: 38791396 PMC: 11121470. DOI: 10.3390/ijms25105358.


Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders.

Li H, Ge Z, Lin K, He W, Chu Q, Zheng M ACS Med Chem Lett. 2024; 15(5):631-639.

PMID: 38746898 PMC: 11089546. DOI: 10.1021/acsmedchemlett.4c00029.


Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma.

Evsen L, Morris P, Thomas C, Ceribelli M Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139762 PMC: 10747288. DOI: 10.3390/ph16121635.